Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

Finishing and polishing effects on ormocer vs methacrylate bulk-fill in Class V restorations

Official title: Impact of Finishing/Polishing Systems on Ormocer Versus Methacrylate Based Bulk Fill Flowable Composite in Class V Restorations: Clinical Study and Laboratory Investigations

Run by Mansoura University · NCT07627295 · Data updated 2026-11-12

This study tests three polishing systems on two types of bulk-fill flowable composites in Class V restorations to see which pairing lasts best on adult patients.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment25 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Dakahlia Governorate)
StatusRecruiting
StartedMay 12, 2026
Main results expectedMay 2028
Study endsMay 2028
Registry record updatedJune 4, 2026
Trial IDNCT07627295 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with three pairs of buccal cervical supragingival carious lesions in anterior teeth, good oral hygiene, and willingness to attend a 2-year follow-up.

Probably not a fit

Patients with poor oral hygiene, ongoing periodontal disease, smoking, or conditions that affect healing may not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares the effect of three different finishing and polishing systems on ormocer and methacrylate-based bulk-fill flowable composites used in Class V restorations of anterior teeth. Each participant receives both materials in paired restorations and is followed at 2 weeks, 6 months, 18 months, and 24 months. Outcomes are assessed using FDI criteria for esthetics, function, and biology to determine which finishing/polishing approach provides the best long-term performance. The trial aims to guide clinicians in selecting the most suitable finishing/polishing system for these materials in Class V cases.

Why it matters

Potential benefit: If successful, this trial could help dentists choose polishing protocols that improve the longevity and appearance of Class V restorations.

How similar studies have gone: Prior work has explored finishing/polishing effects on composites, but this specific comparison between ormocer and methacrylate bulk-fill materials in Class V restorations is not extensively established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Three pairs of buccal cervical supragingival carious lesions in anterior teeth
* Complete and normal occlusion
* Good oral hygiene
* Willingness to attend follow-up and recall visits for 2 years

Exclusion Criteria:

* Teeth requiring direct pulp capping
* Poor oral hygiene or failure to complete the oral hygiene phase
* Chronic periodontitis
* Pulpitis or non-vital teeth
* Current orthodontic treatment
* Presence of parafunctional habits
* Systemic diseases
* Previous or ongoing bleaching procedures
* Smoking patients

Where it's running

  • Faculty of Dentistry, Mansoura University
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Doha M Zahran, master — MSc Postgraduate student ,Conservative Dentistry Department, Faculty of Dentistry, Mansoura University, Mansoura, Egypt.
  • Study coordinator: doha m zahran, master
  • Email: dohazahran96@gmail.com
  • Phone: 00201026336671

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.